Lauren R. Rublin

Panelists are split on where the economy and markets are headed, but agree this year’s selloff has left plenty of bargains.

From biotech to managed care, companies are tackling new challenges in science and business. Our healthcare roundtable experts pick 12 stocks that could win.

Ray Dalio, founder of Bridgewater Associates and author of the new book “Principles for Dealing with the Changing World Order: Why Nations Succeed and Fail,” discusses how social division and polarization could lead to a major domestic conflict.

Our 2023 list will honor leaders and rising stars in the financial-services industry, and in organizations that support it.

At the Barron’s 2023 Roundtable, 10 panelists engaged in a wide-ranging macro discussion about the economy, financial markets, and more. Plus, 9 stock picks.

At the Barron’s 2023 Roundtable, 10 panelists engaged in a wide-ranging macro discussion about the economy, financial markets, and more. Plus, 9 stock picks.

The final installment of this year’s Barron’s Roundtable highlights Deere, Salesforce.com, and other undervalued stocks. Plus, a bevy of bond picks for a rising-rate world.

Adam Seessel founder of Gravity Capital, dumped his “old economy” stocks in the 2010s and embraced the digital revolution. Why he’s still a believer in value investing—and growth stocks.

Weight-loss treatments aren’t the only big deal in medicine. Barron’s 2023 healthcare roundtable explores the best investing opportunities. Where our panelists see bargains now.

Weight-loss treatments aren’t the only big deal in medicine. Barron’s 2023 healthcare roundtable explores the best investing opportunities. Where our panelists see bargains now.